Phenytoin sodium capsules: suspected unfair pricing The CMA investigated alleged excessive and unfair prices for phenytoin sodium capsules under Chapter II of CA98. Remittal case timetable (Case 50908) First published: 8 June 2020 | Date | Milestone | |---|---| | 20 November 2024 | Competition Appeal Tribunal judgment setting aside the CMA’s Infringement Decision and remaking the decision | | 21 F...